featured
Combined PD-L1 and CTLA-4 Inhibition With Targeted Low-Dose or Hypofractionated Radiation for Patients With Metastatic Colorectal Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Clinical Cancer Research
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
A Randomized Trial of Combined PD-L1 and CTLA-4 Inhibition With Targeted Low-Dose or Hypofractionated Radiation for Patients With Metastatic Colorectal Cancer
Clin. Cancer Res 2021 Feb 10;[EPub Ahead of Print], AM Monjazeb, A Giobbie-Hurder, A Lako, EM Thrash, R Brennick, KZ Kao, C Manuszak, RD Gentzler, A Tesfaye, S Jabbour, OB Alese, OE Rahma, JM Cleary, E Sharon, H Mamon, M Cho, H Streicher, HX Chen, MM Ahmed, A Mariño-Enríquez, S Kim-Schulze, S Gnjatic, E Maverakis, A Marusina, A Merleev, M Severgnini, K Pfaff, J Lindsay, JL Weirather, S Ranasinghe, A Spektor, S Rodig, FS Hodi, JD SchoenfeldFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.